NIA‐AA Alzheimer's Disease Framework: Clinical Characterization of Stages-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

NIA‐AA Alzheimer's Disease Framework: Clinical Characterization of Stages

Published:2021-04-06 Issue:6 Volume:89 Page:1145-1156
ISSN:0364-5134
Container-title:Annals of Neurology
language:en
Short-container-title:Ann Neurol

Author:

Petersen Ronald C.¹^ORCID,Wiste Heather J.²,Weigand Stephen D.²,Fields Julie A.³,Geda Yonas E.⁴,Graff‐Radford Jonathan¹^ORCID,Knopman David S.¹^ORCID,Kremers Walter K.²,Lowe Val⁵,Machulda Mary M.³,Mielke Michelle M.²^ORCID,Stricker Nikki H.³,Therneau Terry M.²,Vemuri Prashanthi⁵^ORCID,Jack Clifford R.⁵

Affiliation:

1. Department of Neurology Mayo Clinic Rochester MN

2. Department of Health Sciences Research Mayo Clinic Rochester MN

3. Department of Psychiatry and Psychology Mayo Clinic Rochester MN

4. Department of Neurology Barrow Neurological Institute Phoenix AZ

5. Department of Radiology Mayo Clinic Rochester MN

Funder

Alzheimer's Association

Mayo Foundation for Medical Education and Research

National Institutes of Health

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ana.26071

Reference39 articles.

1. NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease

2. Risk and protective factors for cognitive impairment in persons aged 85 years and older

3. Prevalence of mild cognitive impairment is higher in men: The Mayo Clinic Study of Aging

4. Data Resource Profile: The Rochester Epidemiology Project (REP) medical records-linkage system

5. Mild cognitive impairment as a diagnostic entity

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regulatory considerations for developing remote measurement technologies for Alzheimer’s disease research;npj Digital Medicine;2024-09-04

2. Neuropsychiatric symptoms: Risk factor or disease marker? A study of structural imaging biomarkers of Alzheimer's disease and incident cognitive decline;Human Brain Mapping;2024-09

3. Executive function and cortical thickness in biomarker aMCI;Applied Neuropsychology: Adult;2024-08-14

4. Engineering anti-amyloid antibodies with transferrin receptor targeting improves brain biodistribution and mitigates ARIA;2024-07-26

5. Subjective Cognitive Decline Plus and Longitudinal Assessment and Risk for Cognitive Impairment;JAMA Psychiatry;2024-07-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3